Interferon alfa (Roferon-A®, Viraferon®) – Adjunct to surgery in malignant melanoma

Drug Name (Brand)	Interferon alfa *(Roferon-A®, Viraferon®)*
Indication	Adjunct to surgery in malignant melanoma
Traffic Light Classification	Red
NICE TA (plus link)
Further Information: NICE recommendations, summary of meeting discussions, links to additional supporting docs etc. April 2013: NHS England SCG took over commissioning responsibility for this treatment. September 2015: The TAG noted NG 14 (July 2015) – Assessment and management of melanoma in children, young people and adults which includes recommendations on: * Assessing and staging melanoma * Treating stages 0-II melanoma * Treating stage III melanoma * Treating stage IV melanoma * Follow up after treatment * Managing suboptimal vitamin D levels October 2015: Noted by the Norfolk & Waveney CCGs’ Drugs & Therapeutics Commissioning Group (D&TCG).
Date of TAG recommendation / ratification		5/1/1999	Review Date	1/4/2027